Summation of COVID-19 Federal Responses Archive

Noteworthy stories related to the pandemic are decreasing so this will be our last FEDERAL UPDATE. We will continue to keep membership advised of all the lates…

A new study found the bivalent Omicron booster triggered a strong antibody response against the Omicron variant after 28 days.

NIAID Director Dr. Anthony Fauci is optimistic the COVID-19 situation could be downgraded from pandemic to endemic before he retires at the end of the year.

By mid-September, updated COVID-19 booster shots, targeting BA.4 and BA.5 subvariants of the Omicron variant, will be available.

HHS is beginning to allow individual health care providers to order “Evusheld,” the new antibody therapy developed by AstraZeneca, for small patient groups of …

A CDC analysis found that immunocompromised patients accounted for 12.2% of all COVID-19-related hospitalizations.

COVID-19 nasal vaccines are still in early development stages, however health officials are optimistic that they could potentially prevent infections in the fu…

The FDA announced that it will allow state-licensed pharmacists to directly prescribe Paxlovid to COVID-19 patients.

CMS has announced that it will cover COVID-19 vaccinations for children 5 years old and younger who are covered through Medicare or CHIP.

A pediatrics study has revealed low vaccine efficacy towards the COVID-19 Omicron variant in teens with two vaccine doses, as opposed to teens who have receive…

The FDA’s Advisory Committee recommended the approval of Moderna’s COVID-19 vaccine for children under 5 years old

Data suggests that Omicron sub-variants are more immune-resistant than the original Omicron strain, possibly making retooled vaccines outdated by the time they…

The CDC now recommends that children between the ages of 5 and 11 receive a COVID-19 booster shot. This recommendation comes after the FDA authorized a boost…

The NIH has licensed its stabilized spike protein technology to the World Health Organization. The WHO will utilize the technology to help manufacturers worl…

New research about the cognitive impairment effects of long COVID-19 compares these symptoms to 20 years of cognitive aging and a reduction of 10 IQ points. …

Two variants of Omicron’s BA.2 sub lineage—BA.2.12 and BA.2.12.1—appear to spread about 25% faster than BA.2. The new variants are contagious enough that the…

The FDA granted emergency use authorization of a breath test that can detect COVID-19 infections within as little as three minutes and has a 0.7% rate of fal…

A statistical analysis of reported cases, hospital admissions, reported deaths, and seroprevalence estimates that 43.9% of the global population had been inf…

New research highlights the importance of air ventilation as a COVID-19 mitigation measure. Public health experts are tracking a new COVID-19 sub variant, l…

Increasing rates of norovirus infection are responsible for a wave of stomach flu. Cases are easily confused with COVID-19 as both can cause gastrointestinal…